Methylprednisolone Completed Phase 2 Trials for Chronic B-Lymphocytic Leukemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00558181High-dose Methylprednisolone and Rituximab in High Risk B-CLL